IRIS Accounts Production v25.2.0.378 10246838 Board of Directors Board of Directors 31.12.24 1.1.24 31.12.24 31.12.24 true false true false false true false Ordinary 0 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh102468382023-12-31102468382024-12-31102468382024-01-012024-12-31102468382022-12-31102468382023-01-012023-12-31102468382023-12-3110246838ns15:EnglandWales2024-01-012024-12-3110246838ns14:PoundSterling2024-01-012024-12-3110246838ns10:Director12024-01-012024-12-3110246838ns10:Director22024-01-012024-12-3110246838ns10:Consolidated2024-12-3110246838ns10:ConsolidatedGroupCompanyAccounts2024-01-012024-12-3110246838ns10:PrivateLimitedCompanyLtd2024-01-012024-12-3110246838ns10:Consolidatedns10:SmallEntities2024-01-012024-12-3110246838ns10:Consolidatedns10:AuditExemptWithAccountantsReport2024-01-012024-12-3110246838ns10:SmallCompaniesRegimeForDirectorsReport2024-01-012024-12-3110246838ns10:SmallCompaniesRegimeForAccounts2024-01-012024-12-3110246838ns10:Consolidatedns10:SmallCompaniesRegimeForDirectorsReport2024-01-012024-12-3110246838ns10:Consolidatedns10:SmallCompaniesRegimeForAccounts2024-01-012024-12-3110246838ns10:FullAccounts2024-01-012024-12-3110246838ns10:OrdinaryShareClass12024-01-012024-12-3110246838ns10:Consolidated2024-01-012024-12-3110246838ns10:RegisteredOffice2024-01-012024-12-3110246838ns10:Consolidated2023-01-012023-12-3110246838ns5:CurrentFinancialInstruments2024-12-3110246838ns5:CurrentFinancialInstruments2023-12-3110246838ns5:ShareCapital2024-12-3110246838ns5:ShareCapital2023-12-3110246838ns5:RetainedEarningsAccumulatedLosses2024-12-3110246838ns5:RetainedEarningsAccumulatedLosses2023-12-3110246838ns5:PlantMachinery2024-01-012024-12-3110246838ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-3110246838ns5:WithinOneYearns5:CurrentFinancialInstruments2023-12-3110246838ns10:OrdinaryShareClass12024-12-3110246838ns5:RetainedEarningsAccumulatedLosses2023-12-3110246838ns5:RetainedEarningsAccumulatedLosses2024-01-012024-12-31
















NEILMED HOLDING COMPANY LIMITED

REPORT OF THE DIRECTORS AND

UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024






NEILMED HOLDING COMPANY LIMITED (REGISTERED NUMBER: 10246838)






CONTENTS OF THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024




Page

Company Information 1

Report of the Directors 2

Consolidated Statement of Income and Retained Earnings 3

Consolidated Balance Sheet 4

Company Balance Sheet 6

Notes to the Consolidated Financial Statements 8


NEILMED HOLDING COMPANY LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 DECEMBER 2024







DIRECTORS: Dr K Mehta
Ms. N Mehta





REGISTERED OFFICE: 221 Kenton Lane
Kenton
Harrow
Middlesex
HA3 8RP





REGISTERED NUMBER: 10246838 (England and Wales)





ACCOUNTANTS: Akshar & Company
Chartered Accountants
221 Kenton Lane
Harrow
Middlesex
HA3 8RP

NEILMED HOLDING COMPANY LIMITED (REGISTERED NUMBER: 10246838)

REPORT OF THE DIRECTORS
FOR THE YEAR ENDED 31 DECEMBER 2024

The directors present their report with the financial statements of the company and the group for the year ended 31 December 2024.

PRINCIPAL ACTIVITY
sale of pharmaceutical products and investments in subsidiaries.

DIRECTORS
The directors shown below have held office during the whole of the period from 1 January 2024 to the date of this report.

Dr K Mehta
Ms. N Mehta

DIRECTORS' RESPONSIBILITIES STATEMENT
The directors are responsible for preparing the Report of the Directors and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and the group and of the profit or loss of the group for that period. In preparing these financial statements, the directors are required to:

- select suitable accounting policies and then apply them consistently;
- make judgements and accounting estimates that are reasonable and prudent;
- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's and the group's transactions and disclose with reasonable accuracy at any time the financial position of the company and the group and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and the group and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

This report has been prepared in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

ON BEHALF OF THE BOARD:





Dr K Mehta - Director


11 September 2025

NEILMED HOLDING COMPANY LIMITED (REGISTERED NUMBER: 10246838)

CONSOLIDATED
STATEMENT OF INCOME AND
RETAINED EARNINGS
FOR THE YEAR ENDED 31 DECEMBER 2024

2024 2023
Notes £    £   

TURNOVER 11,688,585 9,969,965

Cost of sales 4,865,596 3,797,917
GROSS PROFIT 6,822,989 6,172,048

Administrative expenses 6,504,018 6,465,257
OPERATING PROFIT/(LOSS) 4 318,971 (293,209 )

Interest receivable and similar income 22 660
PROFIT/(LOSS) BEFORE TAXATION 318,993 (292,549 )

Tax on profit/(loss) 5 89,738 291,798
PROFIT/(LOSS) FOR THE FINANCIAL YEAR 229,255 (584,347 )

Retained earnings at beginning of year 3,629,969 4,214,316

RETAINED EARNINGS FOR THE GROUP AT
END OF YEAR

3,859,224

3,629,969

Profit/(loss) attributable to:
Owners of the parent 229,255 (584,347 )

NEILMED HOLDING COMPANY LIMITED (REGISTERED NUMBER: 10246838)

CONSOLIDATED BALANCE SHEET
31 DECEMBER 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 7 277,577 362,328

CURRENT ASSETS
Stocks 2,520,477 1,967,827
Debtors 8 3,317,086 3,055,494
Cash at bank and in hand 1,288,792 1,967,282
7,126,355 6,990,603
CREDITORS
Amounts falling due within one year 10 3,467,749 3,560,840
NET CURRENT ASSETS 3,658,606 3,429,763
TOTAL ASSETS LESS CURRENT LIABILITIES 3,936,183 3,792,091

CREDITORS
Amounts falling due after more than one year 11 76,859 162,022
NET ASSETS 3,859,324 3,630,069

CAPITAL AND RESERVES
Called up share capital 12 100 100
Retained earnings 13 3,859,224 3,629,969
SHAREHOLDERS' FUNDS 3,859,324 3,630,069

The company and the group are entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2024.

The members have not required the company and the group to obtain an audit of its financial statements for the year ended 31 December 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a) ensuring that the group keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b) preparing financial statements which give a true and fair view of the state of affairs of the company and the group as at the end of each financial year and of the group's profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company and the group.

NEILMED HOLDING COMPANY LIMITED (REGISTERED NUMBER: 10246838)

CONSOLIDATED BALANCE SHEET - continued
31 DECEMBER 2024


The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 11 September 2025 and were signed on its behalf by:




Dr K Mehta - Director



Ms. N Mehta - Director


NEILMED HOLDING COMPANY LIMITED (REGISTERED NUMBER: 10246838)

COMPANY BALANCE SHEET
31 DECEMBER 2024

2024 2023
Notes £    £   
CURRENT ASSETS
Debtors 8 1,196,552 1,150,970
Investments 9 6,643 6,643
Cash at bank and in hand 3,164 17,542
1,206,359 1,175,155
CREDITORS
Amounts falling due within one year 10 10,575 (3,866 )
NET CURRENT ASSETS 1,195,784 1,179,021
TOTAL ASSETS LESS CURRENT LIABILITIES 1,195,784 1,179,021

CAPITAL AND RESERVES
Called up share capital 12 100 100
Retained earnings 13 1,195,684 1,178,921
SHAREHOLDERS' FUNDS 1,195,784 1,179,021

Company's profit/(loss) for the financial year 16,763 (44,803 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

NEILMED HOLDING COMPANY LIMITED (REGISTERED NUMBER: 10246838)

COMPANY BALANCE SHEET - continued
31 DECEMBER 2024


The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 11 September 2025 and were signed on its behalf by:




Dr K Mehta - Director



Ms. N Mehta - Director


NEILMED HOLDING COMPANY LIMITED (REGISTERED NUMBER: 10246838)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

1. STATUTORY INFORMATION

Neilmed Holding Company Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the General Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 25% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Consolidated Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

NEILMED HOLDING COMPANY LIMITED (REGISTERED NUMBER: 10246838)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024

2. ACCOUNTING POLICIES - continued

Pension costs and other post-retirement benefits
The group operates a defined contribution pension scheme. Contributions payable to the group's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 27 (2023 - 21 ) .

4. OPERATING PROFIT/(LOSS)

The operating profit (2023 - operating loss) is stated after charging:

2024 2023
£    £   
Depreciation - owned assets 184,057 130,188

5. TAXATION

Analysis of the tax charge
The tax charge on the profit for the year was as follows:
2024 2023
£    £   
Current tax:
UK corporation tax 89,738 291,798
Tax on profit/(loss) 89,738 291,798

6. INDIVIDUAL INCOME STATEMENT

As permitted by Section 408 of the Companies Act 2006, the Income Statement of the parent company is not presented as part of these financial statements.


NEILMED HOLDING COMPANY LIMITED (REGISTERED NUMBER: 10246838)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024

7. TANGIBLE FIXED ASSETS

Group
Fixtures
Long Plant and and
leasehold machinery fittings
£    £    £   
COST
At 1 January 2024 423,349 46,063 5,082
Additions 99,306 - -
At 31 December 2024 522,655 46,063 5,082
DEPRECIATION
At 1 January 2024 117,143 23,952 1,821
Charge for year 174,573 1,231 277
At 31 December 2024 291,716 25,183 2,098
NET BOOK VALUE
At 31 December 2024 230,939 20,880 2,984
At 31 December 2023 306,206 22,111 3,261

Motor Computer
vehicles equipment Totals
£    £    £   
COST
At 1 January 2024 54,290 1,350 530,134
Additions - - 99,306
At 31 December 2024 54,290 1,350 629,440
DEPRECIATION
At 1 January 2024 23,540 1,350 167,806
Charge for year 7,976 - 184,057
At 31 December 2024 31,516 1,350 351,863
NET BOOK VALUE
At 31 December 2024 22,774 - 277,577
At 31 December 2023 30,750 - 362,328

NEILMED HOLDING COMPANY LIMITED (REGISTERED NUMBER: 10246838)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024

8. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

Group Company
2024 2023 2024 2023
£    £    £    £   
Trade debtors 3,152,292 2,873,775 1,196,552 1,150,970
Other debtors 164,794 181,719 - -
3,317,086 3,055,494 1,196,552 1,150,970

9. CURRENT ASSET INVESTMENTS

Company
2024 2023
£    £   
Shares in group undertakings 6,643 6,643

10. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

Group Company
2024 2023 2024 2023
£    £    £    £   
Trade creditors 578,159 420,558 - -
Amounts owed to group undertakings - - 6,643 6,643
Taxation and social security 261,699 99,437 3,932 (10,509 )
Other creditors 2,627,891 3,040,845 - -
3,467,749 3,560,840 10,575 (3,866 )

11. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

Group
2024 2023
£    £   
Other creditors 76,859 162,022

12. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
100 Ordinary £1 100 100

NEILMED HOLDING COMPANY LIMITED (REGISTERED NUMBER: 10246838)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024

13. RESERVES

Group
Retained
earnings
£   

At 1 January 2024 3,629,969
Profit for the year 229,255
At 31 December 2024 3,859,224

Company
Retained
earnings
£   

At 1 January 2024 1,178,921
Profit for the year 16,763
At 31 December 2024 1,195,684